Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1
Condition(s):COVID-19 InfectionLast Updated:August 10, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):COVID-19 InfectionLast Updated:August 10, 2022Terminated
Condition(s):Adenocarcinoma of the ProstateLast Updated:March 20, 2019Completed
Condition(s):Breast CancerLast Updated:May 14, 2021Completed
Condition(s):Breast CancerLast Updated:October 28, 2022Terminated
Condition(s):Prostate CancerLast Updated:May 10, 2021Terminated
Condition(s):Androgen Deprivation Therapy; Locally Advanced Prostate CancerLast Updated:February 15, 2024Not yet recruiting
Condition(s):Prostate Cancer; Pharmacokinetics of EnzalutamideLast Updated:September 9, 2014Completed
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:August 19, 2019Completed
Condition(s):Metastatic Castration-Resistant Prostate Cancer (mCRPC)Last Updated:November 13, 2023Recruiting
Condition(s):Metastatic Prostate CancerLast Updated:October 21, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.